Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target is a research paper published in Frontiers in Oncology (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: P50 CA095103
NCI NIH HHS
Grant: R01 CA193219
Vanderbilt-Ingram Cancer Center
National Institutes of Health
FWCI
0.90
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals